UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 354

Sortiert nach

How I treat adenovirus in hematopoietic stem cell transplant recipients

Blood, 2010-12, Vol.116 (25), p.5476-5485

2010

Volltextzugriff (PDF)

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Volltextzugriff (PDF)

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Molecular therapy, 2017-01, Vol.25 (1), p.249-258

2017

Volltextzugriff (PDF)

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Volltextzugriff (PDF)

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Cancer discovery, 2018-08, Vol.8 (8), p.972-987

2018

Volltextzugriff (PDF)

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

Cytotherapy (Oxford, England), 2024-08, Vol.26 (8), p.869-877

2024

Volltextzugriff (PDF)

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical cancer research, 2023-01, Vol.29 (2), p.324-330

2023

Volltextzugriff (PDF)

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Current opinion in infectious diseases, 2018-08, Vol.31 (4), p.292-300

2018

Volltextzugriff (PDF)

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Blood, 2013-06, Vol.121 (26), p.5113-5123

2013

Volltextzugriff (PDF)

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

British journal of haematology, 2023-08, Vol.202 (4), p.874-878

2023

Volltextzugriff (PDF)

Fine-tuning the CAR spacer improves T-cell potency

Oncoimmunology, 2016-12, Vol.5 (12), p.e1253656-e1253656

2016

Volltextzugriff (PDF)

Antiviral T-cell therapy

Immunological reviews, 2014-03, Vol.258 (1), p.12-29

2014

Volltextzugriff (PDF)

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

Haematologica (Roma), 2020-01, Vol.105 (1), p.235

2020

Volltextzugriff (PDF)

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

Molecular therapy, 2012-08, Vol.20 (8), p.1622-1632

2012

Volltextzugriff (PDF)

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Clinical cancer research, 2017-07, Vol.23 (14), p.3499-3509

2017

Volltextzugriff (PDF)

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

Molecular therapy, 2014-06, Vol.22 (6), p.1211-1220

2014

Volltextzugriff (PDF)

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.34-34, Article 34

2018

Volltextzugriff (PDF)

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Blood, 2021-05, Vol.137 (19), p.2585-2597

2021

Volltextzugriff (PDF)

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Molecular therapy, 2013-11, Vol.21 (11), p.2113-2121

2013

Volltextzugriff (PDF)

Is cancer gene therapy an empty suit?

The lancet oncology, 2013-10, Vol.14 (11), p.e447-e456

2013

Volltextzugriff (PDF)

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Blood, 2024-04, Vol.143 (17), p.1726

2024

Volltextzugriff (PDF)

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Blood, 2014-06, Vol.123 (25), p.3895-3905

2014

Volltextzugriff (PDF)

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Blood, 2022-04, Vol.139 (17), p.2706-2711

2022

Volltextzugriff (PDF)

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Blood, 2009-11, Vol.114 (19), p.4283-4292

2009

Volltextzugriff (PDF)

1 – 25 von 354

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(322)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(192)
Life Sciences & Biomedicine
(185)
Humans
(130)
Female
(58)
Male
(55)
Immunotherapy
(46)
Hematology
(40)
Medicine, Research & Experimental
(40)
Research & Experimental Medicine
(40)
Immunology
(39)
Animals
(37)
Oncology
(34)
T-Lymphocytes, Cytotoxic - Immunology
(34)
Hematology, Oncology And Palliative Medicine
(33)
Adult
(30)
Biological And Medical Sciences
(30)
Lymphocytes
(27)
Medical Sciences
(26)
Middle Aged
(26)
Antigens
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How I treat adenovirus in hematopoietic stem cell transplant recipients

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

Fine-tuning the CAR spacer improves T-cell potency

Antiviral T-cell therapy

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Is cancer gene therapy an empty suit?

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Aktive Filter

Suchergebnisse filtern